This most recent twist during the Lykos Therapeutics saga threatens A significant overhaul of the company’s system and direction, with Musk ally and billionaire Trader Antonio Gracias appearing to choose to choose the business back again toward its nonprofit drug progress roots and a more Doblinite philosophy.The suggestion from the cartridge rea